Prenuvo and UT Dallas researchers found links between sleep efficiency, visceral fat and brain volume, with long sleepers ...

Mission Therapeutics has begun a 36-patient Phase 1b study of MTX325, a drug aimed at clearing out damaged mitochondria in ...

Swiss fertility heavyweight bets on stem-cell-derived egg maturation – and on ovarian biology as a market worth owning.

After 12 weeks, members of Omada’s GLP-1 Care Track had lost more weight and shifted their body makeup more than people on usual care. A bathroom scale gives you one number and keeps everything else ...

Arrowhead says its RNAi drug crossed the blood-brain barrier in healthy volunteers and sharply lowered tau, a protein tied to Alzheimer’s.

Berlin keynote details Eos SENOLYTIX's pre-clinical results with mitochondrial-targeted geropeptide on healthspan and lifespan.

The Boston company says the deal more than doubles its patient reach and opens a path to brain-based sleep testing in primary care from 2027.

United Therapeutics will test treprostinil SMI in about 40 patients with pulmonary hypertension linked to COPD.

Fitnescity Health opens its 1,000-plus imaging locations to digital health platforms through one API, with Superpower on board. Fitnescity Health says it now has more than 1,000 places across the US ...

Inside XPRIZE Healthspan’s $101m race: how teams are judged, why measurement matters, and what the field gains beyond a single winner. When a prize carries a $101 million price tag, you expect the ...

XellSmart’s off-the-shelf XS411 lifted motor scores in nine patients, and its 30-person Phase II trial has finished enrolling ...